145 related articles for article (PubMed ID: 25988467)
1. Iris heterochromia and unilateral eyelash hypertrichosis.
Rao RC; Ballard TN; Chen TC
JAMA; 2015 May; 313(19):1967-8. PubMed ID: 25988467
[TBL] [Abstract][Full Text] [Related]
2. Hypertrichosis of the eyelashes caused by bimatoprost.
Tosti A; Pazzaglia M; Voudouris S; Tosti G
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
[TBL] [Abstract][Full Text] [Related]
4. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
Hart J; Shafranov G
Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
[TBL] [Abstract][Full Text] [Related]
5. Hypertrichosis of the upper cheek area associated with travoprost treatment of glaucoma.
Ortiz-Perez S; Olver JM
Ophthalmic Plast Reconstr Surg; 2010; 26(5):376-7. PubMed ID: 20622697
[TBL] [Abstract][Full Text] [Related]
6. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
7. [Malar and ciliary hypertrichosis induced by bimatoprost].
Rouxel AM; Roguedas-Contios AM; Misery L
Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):780-1. PubMed ID: 17978721
[No Abstract] [Full Text] [Related]
8. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Stjernschantz JW; Albert DM; Hu DN; Drago F; Wistrand PJ
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
[TBL] [Abstract][Full Text] [Related]
9. Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues.
Krohn J; Hove VK
Arch Ophthalmol; 2008 Jun; 126(6):867-8. PubMed ID: 18541857
[No Abstract] [Full Text] [Related]
10. Skin graft hypertrichosis associated with prostaglandin analog in the treatment of glaucoma.
Shafi F; Madge SN
Ophthalmic Plast Reconstr Surg; 2014; 30(1):e3-5. PubMed ID: 23811595
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
[TBL] [Abstract][Full Text] [Related]
12. Company profits from side effects of glaucoma treatment.
Banaszek A
CMAJ; 2011 Oct; 183(14):E1058. PubMed ID: 21876012
[No Abstract] [Full Text] [Related]
13. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
[TBL] [Abstract][Full Text] [Related]
14. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
Wester ST; Lee WW; Shi W
Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
[TBL] [Abstract][Full Text] [Related]
15. Trichiasis associated with prostaglandin analog use.
Bearden W; Anderson R
Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):320-2. PubMed ID: 15266150
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis.
Yoelin SG; Fagien S; Cox SE; Davis PG; Campo A; Caulkins CA; Gallagher CJ
Dermatol Surg; 2014 Oct; 40(10):1118-24. PubMed ID: 25229783
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological pseudo-Fuchs].
Sevillano Torrado C; Lugo Adán E; Viso Outeiriño E
Arch Soc Esp Oftalmol; 2013 Jul; 88(7):283-5. PubMed ID: 23768478
[TBL] [Abstract][Full Text] [Related]
18. Lower eyelid melanoma during bimatoprost (Lumigan) therapy.
Sun LL; Welch RT; Vu P
Clin Exp Ophthalmol; 2012 Mar; 40(2):213-4. PubMed ID: 22004163
[No Abstract] [Full Text] [Related]
19. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin.
Woodward DF; Tang ES; Attar M; Wang JW
Exp Dermatol; 2013 Feb; 22(2):145-8. PubMed ID: 23278986
[TBL] [Abstract][Full Text] [Related]
20. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
